Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance
BMJ
.
2023 May 26:381:1028.
doi: 10.1136/bmj.p1028.
Authors
Eleanor J Samarasekera
1
,
Christopher E Clark
2
,
Satwinder Kaur
3
,
Riyaz S Patel
4
5
,
Joseph Mills
6
;
Guideline Committee
Affiliations
1
National Institute for Health and Care Excellence, London, UK eleanor.samarasekera@nice.org.uk.
2
University of Exeter Medical School, Primary Care Research Group, Exeter, UK.
3
National Institute for Health and Care Excellence, London, UK.
4
Institute of Cardiovascular Science, University College London, London, UK.
5
Barts Heart Centre, St Bartholomew's Hospital, London, UK.
6
Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
PMID:
37236634
DOI:
10.1136/bmj.p1028
No abstract available
MeSH terms
Cardiovascular Diseases* / prevention & control
Humans
Risk Assessment
Grants and funding
FS/14/76/30933/BHF_/British Heart Foundation/United Kingdom